Skip to main content

Using real-world evidence to support a changing paradigm for cancer screening: A commentary.

Publication ,  Journal Article
Leavy, MB; Starzyk, K; Myers, E; Curhan, G; Gliklich, R
Published in: Pharmacoepidemiol Drug Saf
October 2020

Duke Scholars

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

October 2020

Volume

29

Issue

10

Start / End Page

1312 / 1315

Location

England

Related Subject Headings

  • Predictive Value of Tests
  • Pharmacology & Pharmacy
  • Neoplasms
  • Mass Screening
  • Humans
  • Early Detection of Cancer
  • Data Collection
  • Bias
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Leavy, M. B., Starzyk, K., Myers, E., Curhan, G., & Gliklich, R. (2020). Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf, 29(10), 1312–1315. https://doi.org/10.1002/pds.5104
Leavy, Michelle B., Kathryn Starzyk, Evan Myers, Gary Curhan, and Richard Gliklich. “Using real-world evidence to support a changing paradigm for cancer screening: A commentary.Pharmacoepidemiol Drug Saf 29, no. 10 (October 2020): 1312–15. https://doi.org/10.1002/pds.5104.
Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R. Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1312–5.
Leavy, Michelle B., et al. “Using real-world evidence to support a changing paradigm for cancer screening: A commentary.Pharmacoepidemiol Drug Saf, vol. 29, no. 10, Oct. 2020, pp. 1312–15. Pubmed, doi:10.1002/pds.5104.
Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R. Using real-world evidence to support a changing paradigm for cancer screening: A commentary. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1312–1315.

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

October 2020

Volume

29

Issue

10

Start / End Page

1312 / 1315

Location

England

Related Subject Headings

  • Predictive Value of Tests
  • Pharmacology & Pharmacy
  • Neoplasms
  • Mass Screening
  • Humans
  • Early Detection of Cancer
  • Data Collection
  • Bias
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences